Ecuador vs Kazakhstan: New or unknown treatment history cases: Pulmonary, bacteriologically
Ecuador
5,613
in 2023
Kazakhstan
5,483
in 2023
Ecuador rank
57th
Kazakhstan rank
59th
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- Ecuador
- Kazakhstan
How they compare
Ecuador currently reports 5,613 against 5,483 in Kazakhstan, a difference of 130.
The two have swapped places 1 time across 11 shared years of data; in 2013 it was Kazakhstan ahead.
Ecuador ranks 57th and Kazakhstan ranks 59th of 197 countries.
Kazakhstan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ecuador | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3,970 | 6,970 | 3,000 | Kazakhstan |
| 2020s | 4,512 | 5,336 | 824.25 | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, Ecuador or Kazakhstan?
- Ecuador, at 5,613 against 5,483 in Kazakhstan as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between Ecuador and Kazakhstan?
- 130, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Kazakhstan?
- 11 years are reported by both, from 2013 to 2023.
- How do Ecuador and Kazakhstan rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- Ecuador ranks 57th and Kazakhstan ranks 59th of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.